Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus (Q36043971)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
scientific article

    Statements

    Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus (English)
    M J Davies
    B D Chubb
    I C Smith
    W J Valentine
    1 March 2012
    313-320

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit